Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

When diversified investments are defeated by the craze of technology stock concentration, actively managed funds face a wave of trillions of redemptions.
.png)
HK Bull/Bear Outstanding Qty Ratio(59:41) | December 27th

NVIDIA Corporation (NVDA.US) partners with Groq: The era of AI inference is approaching, the high-profit myth may face a test.
When diversified investments are defeated by the craze of technology stock concentration, actively managed funds face a wave of trillions of redemptions.

HK Bull/Bear Outstanding Qty Ratio(59:41) | December 27th
.png)
NVIDIA Corporation (NVDA.US) partners with Groq: The era of AI inference is approaching, the high-profit myth may face a test.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


